Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

Clinical trials for Albuterol Spiros completed

June 6, 1997

Potent LT biosynthesis inhibitors described by Abbott

June 6, 1997

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

June 4, 1997

PPL Therapeutics reports positive phase I results for AAT

June 3, 1997

Antiallergic/antiasthmatic agents from Sumitomo Metal

June 2, 1997

T Cell Sciences completes patient enrollment for reperfusion injury trial

June 2, 1997

Positive preclinical results for Inflazyme's Apanol

June 2, 1997

U.K. introduction for Nasonex

May 29, 1997

Selective M3 antagonists from Banyu

May 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...